Medical Science Liaison
Job Description
Key Skills Required
Master these to land this role
Want to know if you're a match for this job?
At Freenome, we are seeking an MSL to help define and grow the Freenome’s presence. The MSL will interact with key clinical decision-makers that influence or manage the use of screening products. This role will be responsible for engaging clinicians (primary care physicians, oncologists, gastroenterologists, pathologists, APPs etc.) and managed care/payor customers. The ideal candidate is a professional with a proven track record identifying the KOLs and payors nationally, and addressing the clinical knowledge gaps across a wide range of customers by communicating impactful scientific information. You are passionate about patient care, and you will have a significant impact on the continued growth of an organization dedicated to changing the entire landscape of cancer.
The role reports to the VP, Medical Affairs and Advocacy.
KOL Engagement:
- Identify and develop relationships with key decision makers in academic and community clinics, hospital systems, payor/managed care organizations, and other institutions that influence or manage the use of screening products.
- Collaborate with clinical and payor customers to understand their needs, knowledge gaps, challenges, and evidence requirements for clinical integration, reimbursement, and coverage.
- Develop timely and strategic territory/account plans to address customer needs.
- Educate and conduct meaningful scientific exchange with clinicians on the clinical attributes of Freenome products.
- Educate managed care/payors on the clinical value of Freenome products and services to drive plan inclusion and appropriate utilization.
- Providing support for on-site oral presentations, data reviews, and interactive education events for Key Opinion Leaders (KOLs).
Thought Leadership and Industry Awareness:
- Stay abreast of the latest scientific and clinical advancements, market trends, and regulatory guidelines relevant to our products, specifically in relation to market access, clinical, IDN, and payor environments.
- Represent the company at industry conferences, meetings, and other events as a thought leader and fostering key relationships.
- Assist in organizing forums and events for KOLs to discuss clinical challenges, unmet needs, and potential product improvements
- Identify trends impacting patient access to blood based cancer screening.
- Critically reviewing new publications and research findings to help develop educational slides, which are then submitted for approval to Medical Affairs and Marketing.
Strategic Partnerships:
- Collaborating with Sales executives to identify and advise on strategic partnership opportunities.
- Promote effective compliant collaboration with key internal and external stakeholders.
- Closing strategic and tactical alignment with commercial field-based teams to ensure appropriate medical support.
- Build field medical territories for commercial launch.
Investigator Initiated Studies:
- Identify investigator initiated study proposals that align with Freenome SMA strategies.
- Present investigator study proposals to cross functional partners in clinical development and scientific medical affairs in support of research activities, including clinical trials, registries, ISTs, and/or RWE.
Must haves:
- Advanced degree in medical or health sciences (e.g. MS/MD/DO/PhD/PharmD).
- 5+ years relevant industry (diagnostic, pharmaceutical, oncology) experience required.
- Medical science liaison experience (oncology/diagnostic industries).
- In-depth scientific and/or therapeutic knowledge.
- Demonstrated understanding of clinical trial management.
- Working knowledge of regulatory guidance and reporting requirements.
- Exceptional organizational and time management skills.
- Strong presentations skills including excellent verbal and written communication.
- Strong interpersonal skills and demonstrated ability to work effectively in a cross functional team.
- A self-starter with a results-driven mentality and positive attitude.
- Computer proficiency in Excel, Word, PowerPoint, Adobe and Google’s office (Drive, Sheets, Docs, Slides, Forms).
Nice to haves:
- Existing relationships with key opinion leaders and affiliated institutions.
How would you rate this job post?
See what other professionals think about this role.
Similar Opportunities
More Openings at Freenome
Explore Top Companies in this Space
Enveda Biosciences
Biotechnology / AI Drug Discovery / Life Sciences / TechBio
Lycia Therapeutics
Biotechnology & Targeted Protein Degradation (TPD) / Lysosomal Targeting Chimeras (LYTACs) / Autoimmune, Inflammation & Oncology Therapeutics
Replimune
Biotechnology Research / Oncology / Immunotherapy
Veracyte
Biotechnology / HealthTech / Molecular Diagnostics
Freenome
View Company ProfileFreenome (operating under freenome.com) is a high-growth biotechnology and molecular diagnostics company that utilizes a proprietary AI-driven multiomics platform to pioneer non-invasive blood tests for early-stage cancer detection. Founded in 2014, the company shifts the paradigm of cancer screening away from isolated, single-analyte genomic testing. Instead, Freenome's platform integrates cell-free DNA (cfDNA), methylation patterns, genomic fragments, and programmatic protein biomarkers with advanced machine learning models to capture complex tumor signals and systemic immune responses at their earliest, most treatable stages. The company's foundational asset, the SimpleScreen colorectal cancer screening blood test, demonstrated exceptional clinical validation through its massive, prospective PREEMPT CRC clinical trial published in JAMA, meeting major efficacy endpoints for sensitivity and specificity. Capitalizing on this multiomic infrastructure, Freenome is aggressively scaling its diagnostic pipeline into a comprehensive Multi-Cancer Early Detection (MCED) portfolio targeting lung, pancreatic, and other high-mortality malignancies. Freenome has secured monumental, multi-million-dollar strategic commercialization and technology agreements with dominant industry pioneers, including a major global expansion partnership with Roche and an extensive distribution and licensing framework with Exact Sciences. Backed by over $1.4 billion in total funding from premier healthcare, tech, and life sciences institutional investors—including Andreessen Horowitz, Bain Capital Life Sciences, RA Capital, and Perceptive Advisors—Freenome entered into a definitive business combination agreement with Perceptive Capital Solutions Corp in late 2025 to transition into a publicly traded entity on the Nasdaq under the ticker FRNM. Headquartered in Brisbane, California, the organization operates sophisticated, CLIA-certified laboratory facilities and is led by industry veteran Dr. Aaron Elliott as Chief Executive Officer.
Safety First
- Never pay for a job application.
- Do not share sensitive bank info.
- Verify the client before starting work.
